Human Estradiol CLIA kit Cat. No.:DEEL0274 Intended use
Enzyme Immunoassay for the Quantitative Determination of ESTRADIOL (E2) in Human Serum or plasma General Description
Estradiol (E2) is a C18 steroid hormone with a phenolic A ring. This steroid hormone has a molecular weight of 272.4. It is the most potent natural Estrogen, produced mainly by the ovary, placenta, and in smaller amounts by the adrenal cortex, and the Estradiol (E2) is secreted into the blood stream where 98% of it circulates bound to sex hormone binding globulin (SHBG). To a lesser extent it is bound to other serum proteins such as albumin. Only a tiny fraction circulates as free hormone or in the conjugated form. Estrogenic activity is effected via estradiol-receptor complexes which trigger the appropriate response at the nuclear level in the target sites. These sites include the follicles, uterus, breast, vagina, urethra, hypothalamus, pituitary and to a In non-pregnant women with normal menstrual cycles, estradiol secretion follows a cyclic, biphasic pattern with the highest concentration found immediately prior to ovulation. The rising estradiol concentration is understood to exert a positive feedback influence at the level of the pituitary where it influences the secretion of the gonadotropins, follicle stimulating hormone (FSH), and luteinizing hormone (LH), which are essential for follicular maturation and ovulation, respectively. Following ovulation, estradiol levels fall rapidly until the luteal cells become active resulting in a secondary gentle rise and plateau of estradiol in the luteal phase. During pregnancy, maternal serum Estradiol levels increase considerably, to well above the pre-ovulatory peak levels and high levels are sustained throughout pregnancy.
Serum Estradiol measurements are a valuable index in evaluating a variety of menstrual dysfunctions such as precocious or delayed puberty in girls and primary and secondary amenorrhea and menopause. Estradiol levels have been reported to be syndromes, gynaecomastia and testicular tumors. In cases of infertility, serum Estradiol measurements are useful for monitoring induction of ovulation following treatment with, for example, clomiphene citrate, LH-releasing hormone (LH-RH), or exogenous hyperstimulation for in vitro fertilization (IVF), serum estradiol concentrations are usually monitored daily for optimal timing of human chorionic gonadotropin (hCG) administration and oocyte collection. The Estradiol (E2) EIA kits are designed for the measurement of total Estradiol in human serum or plasma.
Principle Of The Test
The E2 EIA is based on the principle of competitive binding between E2 in the test specimen and E2-HRP conjugate for a constant amount of rabbit anti-Estradiol. In the incubation, goat anti-rabbit IgGcoated wells are incubated with 25 μl E2 standards, controls, patient samples, 100 μl Estradiol-HRP Conjugate Reagent and 50 μl rabbit anti-Estradiol reagent at room temperature (18-25°C) for 90 minutes. During the incubation, a fixed amount of HRP-labeled E2 competes with the endogenous E2 in the standard, sample, or quality control serum for a fixed number of binding sites of the specific E2 antibody. Thus, the amount of E2 peroxidase conjugate immunologically bound to the well progressively decreases as the concentration of E2 in the specimen increases. Unbound E2 peroxidase conjugate is then removed and the wells washed. A solution of chemiluminescent Creative Diagnostics. All rights reserved
45-16 Ramsey Road Shirley, NY 11967, USA substrate is then added and read relative light units (RLU) with a Luminometer. The intensity of the emitting light is proportional to the amount of enzyme present and is inversely related to the amount of unlabeled E2 in the sample. By reference to a series of E2 standards assayed in the same way, the concentration of E2 in the unknown sample is quantified.
Reagents And Materials Provided
1. Goat Anti-Rabbit IgG-coated microtiter wells, 96 wells 2. Estradiol Reference Standards: 0, 10, 30, 100, 300, and 1000 pg/ml. Liquid, 0.50 ml each, ready to use.
4. Estradiol-HRP Conjugate Reagent , 12 ml Materials Required But Not Supplied
• Precision pipettes: 0.05ml, 0.1ml, 0.2ml • Glass tube or flasks to mix Chemiluminescence Reagent A and B.
Reagent Preparation
1. All reagents should be allowed to reach room temperature (18-25°C) before use, and mixed by gently inverting or swirling prior to use. Do NOT induce foaming.
2. To prepare substrate solution, make a 1:1 mixing of Reagent A with Reagent B right before use. Mix gently to ensure complete mixing. Discard excess after use.
3. Dilute 1 volume of Wash Buffer (50x) with 49 volumes of distilled water. For example, Dilute 15 ml of Wash Buffer (50x) into 735 ml of distilled water to prepare 750 ml of washing buffer (1x). Mix well before use.
Assay Steps
1. Secure the desired number of coated wells in the holder.
2. Dispense 25 μl of standards, specimens and controls into appropriate wells.
3. Dispense 50 μl of rabbit anti-Estradiol (E2) reagent to each well.
4. Dispense 100 μl of Estradiol-HRP Conjugate Reagent into each well.
5. Thoroughly mix for 30 seconds. It is very important to mix them completely.
6. Incubate at room temperature (18-25°C) for 90 minutes.
7. Rinse and flick the microwells 5 times with washing buffer(1X).
8. Strike the wells sharply onto absorbent paper to remove residual water droplets.
Creative Diagnostics. All rights reserved
45-16 Ramsey Road Shirley, NY 11967, USA 9. Dispense 100 μl Chemiluminescence substrate solution into each well. Gently mix for 5 seconds.
10. Read wells with a chemiluminescence microwell reader 5 minuters later. (between 5 and 20 min. after dispensing the 1. The wash procedure is critical. Insufficient washing will result in poor precision and falsely elevated absorbance readings.
2. If there are bubbles existing in the wells, the false readings will be created. Please use distilled water to remove the bubbles Calculation
Calculate the average read relative light units (RLU) for each set of reference standards, control, and samples.
We recommend using proper software to calculate the results. The best curve fitting used in the assays are 4-parameter regrassion or cubic spline regaression. If the software is not available, construct a standard curve by plotting the mean RLU obtained for each reference standard against E2concentration in Pg/ml on linear graph paper, with RLU on the vertical (y) axis and concentration on the horizontal (x) axis.
Using the mean absorbance value for each sample, determine the corresponding concentration of E2 in pg/ml from the standard Typical Standard Curve
Results of a typical standard run are shown below. This standard curve is for the purpose of illustration only, and should not be used to calculate unknowns. It is required that running assay together with a standard curve each time. The calculation of the sample values must be based on the particular curve, which is running at the same time.
Expected Normal Values
Each laboratory should establish its own normal range based on the patient population. The Estradiol EIA was performed on randomly selected outpatient clinical laboratory samples. The results of these determinations are as follows: Females: postmenopausal phase < 18 pg/ml Creative Diagnostics. All rights reserved
45-16 Ramsey Road Shirley, NY 11967, USA prepubertal children, normal < 10 pg/ml The minimum detectable concentration of the Estradiol ELISA assay as measured by 2 SD from the mean of a zero standard is CLINICAL APPLICATION
1. Assessment of Female Menstrual Dysfunctions: Elevated E2 can be used in the evaluation of precocious puberty in girls. However, extensive ancillary aids are required for E2 measurements are frequently utilized in the assessment of hypoestrogenism in cases of delayed puberty, primary and secondary amenorrhea, and menopause. In hypoestrogenism women, E2 concentrations are usually <30 pg/ml.
2. Assessment of Excessive Estrogen Production in Women: In pregnant women, E2 concentrations will >1,000 pg/ml. In non-pregnant women, excessive estrogen may indicate ovarian E2 is often measured to monitor ovulation induction and for patient follow-up during infertility therapy, e.g. in vitro fertilization E2 measurement is used in the differential diagnosis gynecomastia, feminizing syndromes, hypogonadism and testicular tumors.
1. Tsang, B.K., Armstrong, D.T. and Whitfield, J.F., Steroid biosynthesis by isolated human ovarian follicular cells in vitro, J. Clin.
Endocrinol. Metab., 1980; 51: 1407-1411.
2. Gore-Langton, R.E. and Armstrong, D.T., Follicular steroidogenesis and its control. In: Knobil, E., and Neill, J. et al., ed. ThePhysiology of Reproduction. Raven Press, New York; 1988: 331-385.
3. Hall, P.F., Testicular steroid synthesis: Organization and regulation. In: Knobil, E., and Neill, J. et al., ed. The Physiology ofReproduction. Raven Press, New York; 1988: 975-998.
Creative Diagnostics. All rights reserved
45-16 Ramsey Road Shirley, NY 11967, USA


Tabela hospitalar_fiosaúde_rj.xls

1 - HONORÁRIOS MÉDICOS 1.1 Os honorários médicos serão pagos de acordo com a tabela do FioSaúde. 1.2 Os Serviços Auxiliares de Diagnose e Terapia – SADT, serão pagos de acordo com a tabela do FioSaúde. 1.3 Para os procedimentos médicos realizados em regime de hospital-dia, deverá ser observado:1.3.1 São considerados procedimentos passíveis de hospital-dia, aqueles com indicaç

Travel_questionnaire sept 1

Branksomewood Healthcare Centre TRAVEL VACCINATION QUESTIONNAIRE PATIENT TO COMPLETE THIS SIDE DOB . GP …………………. DAYTIME CONTACT TEL NO . PLEASE LIST ALL COUNTRIES TO BE VISITED - IN ORDER- INCLUDING STOP-OVERS LENGTH OF STAY What type of accommodation are you staying in? Hotel / Self -Catering / Backpacking/Cruise Reason for travel? Holiday / Work

Copyright © 2018 Medical Abstracts